recent articles

Agilent: Providing a comprehensive digital diagnostic pathology system for enhanced clinical utility SANTA CLARA, Calif., March 08, 2023 Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with...

Akoya Collaborating with Agilent to Catalyze Precision Medicine We recently announced a partnership with Agilent to develop multiplex diagnostic solutions for tissue analysis and to commercialize workflow solutions for these...

Agilent and Akoya Biosciences: Will commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development SANTA CLARA, Calif, & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Agilent Technologies,...

Agilent Technologies Inc. (NYSE: A), a leader in life sciences, diagnostics, and applied chemical markets, and Visiopharm, a leader in AI-based digital pathology, today announced the signing of a worldwide distribution agreement, enabling...

This is the fourth in a series of CEO short interviews about their views on their company, the digital pathology market, lessons learned and perhaps a little insight into their business principles.  My personal thanks to Ms. Shiposh and the...

OR

platinum partners

gold partners

Silver Partners

Media Partners